Kanghong Pharmaceutical: Received notification of approval for clinical trial of drug

On the evening of May 14th, Kanghong Pharmaceuticals announced that the company has recently received the Drug Clinical Trial Approval Notice for KH607 Tablets issued by the National Medical Products Administration, allowing the company to conduct clinical trials for the treatment of postpartum depression.